Bioactive Technologies For Bone Replacement
This article was originally published in Start Up
| Table |
|---|
Advertisement
Related Companies
- Medtronic PLC
- Stryker Corp.
- Stryker Biotech
- RTI Surgical Inc.
- Synthes Inc.
- Musculoskeletal Transplant Foundation
- Orthovita Inc.
- ApaTech Ltd.
- Baxter International Inc.
- DePuy Synthes
- Johnson & Johnson
- NuVasive Inc.
- Orthofix Inc.
- Orthofix Medical Inc.
- Osiris Therapeutics Inc.
- AlloSource
- Progentix Orthobiology BV
- Alphatec Holdings Inc.
- Brigham and Women's Hospital
- Pfizer Inc.
- Wyeth
- Etex Corp.
- Scil Technology GmbH
- Adocia SAS
- BioMimetic Therapeutics Inc.
- Novartis Vaccines & Diagnostics Inc.
- Novartis AG
- American Reagent Inc.
- Daiichi Sankyo Co. Ltd.
- Cerapedics Inc.
- Bone Biologics Corp.
- University of California, Los Angeles
- Affinergy Inc.
- Duke University
- Kuros Biosurgery AG
- University of Southern California
- Harvest Technologies Corp.
Related Deals
- Baxter to pay $240mm for ApaTech
- NuVasive buys Osiris's Osteocel business
- NuVasive makes equity investment in Progentix
- Pfizer acquires Wyeth in $67bn deal
- Medtronic helps develop Scil's rhGDF-5
- Pfizer gets global rights to Scil's rhCD-RAP; rights returned
- Adocia brings in €14mm through its Series B round
- Affinergy, Synthes sign multi-year device agreement
- Baxter, Kuros Biosurgery in tissue repair deal; then Kuros regains rights to most candidates
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SC091966
Ask The Analyst
Please Note: Click here for more information on the Ask the Analyst service.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
SC091966
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.